C

Crescent Biopharma

Clinical-stage biotech developing solid-tumor therapies

Senior Director - Quality Control

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeWaltham, MA, USA

About the Job

Requirements

  • A bachelor's degree in life sciences, analytical sciences, biochemistry, pharmaceutical sciences, or a related discipline is required.
  • A minimum of 10–12 years of progressive experience in biologics quality control, analytical development, or related CMC functions, including leadership of good manufacturing practice quality control operations in an outsourced environment.
  • Experience with biologics analytical methods, including cell-based bioassays and potency assays.
  • Experience supporting biologics from clinical development through Phase 3, process performance qualification, BLA/MAA, and commercial readiness.
  • Experience transitioning methods from development into routine good manufacturing practice quality control use, including qualification, validation, transfer, implementation, performance monitoring, and lifecycle management.
  • Experience with release and stability testing, specifications, reference standards and critical reagents, out-of-specification, out-of-trend and out-of-expectation investigations, analytical trending, deviations, corrective and preventive actions, and change control.
  • Experience overseeing contract development and manufacturing organization quality control functions and contract laboratories, including qualification, governance, investigations, capacity, performance, and issue resolution.
  • Knowledge of global good manufacturing practice regulations, FDA/EMA/ICH guidance, compendial expectations, data integrity, 21 CFR Part 11 and Annex 11, and phase-appropriate application across development and commercial operations.
  • Experience supporting regulatory submissions, health authority questions, pre-approval inspections, and commercial inspection readiness.
  • Ability to establish clear roles and effective collaboration among Analytical Sciences, Quality Control, GMP Quality Assurance, CMC/Technical Operations, Regulatory Affairs, Supply Chain, and external partners.
  • Ability to travel to external sites as needed.

Responsibilities

  • Define and implement Crescent's phase-appropriate quality control strategy and operating model across early development, Phase 3, process performance qualification, regulatory submission, and commercialization, with clear decision rights and handoffs among Analytical Sciences, Quality Control, and GMP Quality Assurance.
  • Oversee quality control activities for drug substance, drug product, intermediates, finished goods, in-process, release, characterization, and stability testing across the portfolio.
  • Provide quality control oversight and operational requirements during early development while Analytical Sciences leads method development, characterization, qualification, validation strategy, and method maturation through process performance qualification readiness.
  • Partner with Analytical Sciences on integrated Phase 3 and process performance qualification readiness, including method validation and transfer, laboratory qualification, specifications, reference standards and critical reagents, stability, sample management, and testing timelines.
  • Lead quality control execution oversight for method transfer, validation, and laboratory readiness; following transition to good manufacturing practice quality control operations, own routine method lifecycle management, performance monitoring, changes, revalidation, transfers, and remediation.
  • Lead outsourced good manufacturing practice quality control operations, including sample management and testing coordination, and ensure timely, compliant release and stability testing for clinical supply, process performance qualification, batch disposition, regulatory commitments, and future commercial supply.
  • Partner with Analytical Sciences, CMC, Regulatory Affairs, and Quality Assurance on specifications and stability strategy; lead operational implementation, stability execution, data review, trending, and escalation within the quality control network.
  • Establish and oversee reference standard and critical reagent programs, including qualification, bridging, inventory, monitoring, replacement, and lifecycle planning.
  • Provide technical leadership for out-of-specification, out-of-trend, out-of-expectation, atypical results, invalid assays, laboratory deviations, corrective and preventive actions, and change controls, ensuring scientifically sound, timely investigations and risk-based escalation.
  • Lead selection, onboarding, qualification, governance, and performance management of contract development and manufacturing organization quality control functions and contract laboratories, including agreements, capacity, metrics, issue management, data integrity, and inspection readiness.
  • Provide quality control input to CMC and regulatory strategies and support investigational new drug/IMPD, BLA/MAA, health authority, and inspection activities; ensure commitments are implemented within the laboratory network.
  • Lead alliance management with business partners on quality control matters, including governance, roles and responsibilities, shared testing and release requirements, issue escalation, decision-making, and alignment on development, regulatory, and future commercial priorities.
  • Establish scalable quality control procedures, systems, metrics, budgeting, forecasting, and resource plans; support compliant use of laboratory information management systems, stability, analytical data, and trending tools, and build internal quality control capability as Crescent advances toward commercialization.
  • Mentor staff and consultants and foster a culture of scientific rigor, collaboration, accountability, inclusion, and continuous improvement while staying current with evolving good manufacturing practice, ICH, compendial, and industry expectations.

Desired Qualifications

  • An advanced degree.
  • Experience with antibody-drug conjugates and other complex biologic modalities.
  • Experience with bispecific antibodies, antibody-drug conjugates, or other complex modalities.

About the Company

Crescent Biopharma

Clinical-stage biotech developing solid-tumor therapies

Crescent Biopharma develops oncology therapies for solid tumors, led by CR-001, a tetravalent bispecific antibody that blocks PD-1 and VEGF to boost anti-tumor immunity while inhibiting tumor blood vessel growth. CR-001 sits in a global Phase 1/2 ASCEND trial, and the pipeline also includes CR-002, an anti-PD-L1 antibody-drug conjugate, and CR-003, an ITGB6-targeted ADC. The company differentiates itself by combining immune checkpoint blockade with VEGF inhibition and other targeted modalities to build an immuno-oncology backbone for solid tumors, supported by strategic partnerships and substantial private placements. Crescent’s goal is to advance multi-agent regimens toward regulatory approval and commercial development for patients with solid tumors.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2003

Recently Posted Jobs

Explore more opportunities at Crescent Biopharma

See more jobs